tiprankstipranks
Theralink Technologies (THER)
OTHER OTC:THER
US Market

Theralink Technologies (THER) Stock Price & Analysis

23 Followers

THER Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.02
Volume1.87M
Average Volume (3M)N/A
Market Cap
$5.54M
Enterprise Value$6.69M
Total Cash (Recent Filing)$24.27K
Total Debt (Recent Filing)$1.17M
Price to Earnings (P/E)-6.7
Beta1.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,151,499,919
10 Day Avg. Volume3,201,717
30 Day Avg. VolumeN/A
Standard Deviation6.66
R-Squared0.03
Alpha0.75
Financial Highlights & Ratios
Price to Book (P/B)-0.10
Price to Sales (P/S)9.75
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.66
Enterprise Value/Gross Profit19.49
Enterprise Value/Ebitda-0.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

<0.01%0.00%0.00%99.99%
<0.01%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
99.99% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

THER FAQ

What was Theralink Technologies’s price range in the past 12 months?
Currently, no data Available
What is Theralink Technologies’s market cap?
Currently, no data Available
When is Theralink Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theralink Technologies’s earnings last quarter?
Currently, no data Available
Is Theralink Technologies overvalued?
According to Wall Street analysts Theralink Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Theralink Technologies pay dividends?
    Theralink Technologies does not currently pay dividends.
    What is Theralink Technologies’s EPS estimate?
    Theralink Technologies’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Theralink Technologies have?
    Theralink Technologies has 6,151,500,000 shares outstanding.
      What happened to Theralink Technologies’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Theralink Technologies?
      Currently, no hedge funds are holding shares in THER
      ---

      Theralink Technologies Stock Smart Score

      N/A
      Not Ranked
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Fundamentals

      Return on Equity
      Trailing 12-Months
      Asset Growth
      -45.06%
      Trailing 12-Months

      Company Description

      Theralink Technologies

      OncBioMune Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its products include vaccines, PA-OBC, and PGT-RC. The company was founded on March 18, 2005 and is headquartered in Baton Rouge, LA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Viveve Medical
      Onconova Therapeutics
      Aptose Biosciences
      Molecular Templates
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis